Amgen Retained Earnings (Accumulated Deficit) 2010-2024 | AMGN

Amgen retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-27.124B, a 6.2% increase year-over-year.

  • Amgen retained earnings (accumulated deficit) for 2023 were $-26.549B, a 7.24% decline from 2022.
  • Amgen retained earnings (accumulated deficit) for 2022 were $-28.622B, a 16.35% increase from 2021.
  • Amgen retained earnings (accumulated deficit) for 2021 were $-24.6B, a 14.91% increase from 2020.

Amgen Retained Earnings (Accumulated Deficit) 2010-2024 | AMGN

  • Amgen retained earnings (accumulated deficit) for 2023 were $-26.549B, a 7.24% decline from 2022.
  • Amgen retained earnings (accumulated deficit) for 2022 were $-28.622B, a 16.35% increase from 2021.
  • Amgen retained earnings (accumulated deficit) for 2021 were $-24.6B, a 14.91% increase from 2020.